Evaluation of Silodosin in Comparison to Tamuslosin in Treatment of Benign Prostatic Hyperplasia with lower Urinary Tract Symptoms: A Prospective Study

Safety and Efficacy of Silodosin versus Tadalafil in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms; A prospective comparative study

Prospective Comparative Study between Silodosin 8 mg Versus Combination of Tadalafil 5mg and Silodosin 4mgfor treatment of Lower Urinary Tract Symptoms related to Benign Prostati

Efficacy of Silodosin versus Sildosin plus Tadalafil as medical expulsive therapy for lower ureteric stones: A prospective randomized placebo controlled study

The effect of silodosin versus darifenacin versus a combination of both drugs on ureteric stent-related symptoms

Effectiveness and Safety of Silodosin in Treatment of Premature Ejaculation: Placebo Double Blind Control Study

Single Versus Double Dose Tamsulosin for Patients with Moderate or Severe Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: Prospective Randomized Study

Comparative study between monotherapy (tamsulosin 0.4mg versus tadalafil 5 mg) versus combined therapy in treatment of lower urinary tract symptoms of benign prostatic hyperplasia

Study of the Effect of Tamsulosin HCl (an Alpha-1 Receptor Antagonist) as a Medical Expelling Agent on Subsequent Ureteroscopic Procedure for Treatment of Lower Ureteric Stones

Options of Medical Management for Benign Prostatic Hyperplasia: Review Article